Access the full text.
Sign up today, get DeepDyve free for 14 days.
T. Batchelder, M. Barricks (1995)
The Wisconsin Epidemiologic Study of Diabetic Retinopathy.Archives of ophthalmology, 113 6
S. Reddy, A. Hu, S. Schwartz (2009)
Ultra Wide Field Fluorescein Angiography Guided Targeted Retinal Photocoagulation (TRP)Seminars in Ophthalmology, 24
P. Mitchell, F. Bandello, U. Schmidt-Erfurth, G. Lang, P. Massin, R. Schlingemann, F. Sutter, C. Simader, G. Burian, O. Gerstner, A. Weichselberger (2011)
The RESTORE study: ranibizumab monotherapy or combined with laser versus laser monotherapy for diabetic macular edema.Ophthalmology, 118 4
H. King, R. Aubert, W. Herman (1998)
Global Burden of Diabetes, 1995–2025: Prevalence, numerical estimates, and projectionsDiabetes Care, 21
K. Shimizu, Yoshiharu Kobayashi, K. Muraoka (1981)
Midperipheral fundus involvement in diabetic retinopathy.Ophthalmology, 88 7
P. Massin, F. Bandello, J. Garweg, L. Hansen, S. Harding, M. Larsen, P. Mitchell, D. Sharp, U. Wolf-Schnurrbusch, M. Gekkieva, A. Weichselberger, S. Wolf (2010)
Safety and Efficacy of Ranibizumab in Diabetic Macular Edema (RESOLVE Study)Diabetes Care, 33
R. Beck, A. Edwards, L. Aiello, N. Bressler, F. Ferris, A. Glassman, Elizabeth Hartnett, M. Ip, Judy Kim, C. Kollman (2009)
Three-year follow-up of a randomized trial comparing focal/grid photocoagulation and intravitreal triamcinolone for diabetic macular edema.Archives of ophthalmology, 127 3
T. Friberg, Anurag Gupta, Jenny Yu, Linda Huang, I. Suñer, C. Puliafito, S. Schwartz (2008)
Ultrawide angle fluorescein angiographic imaging: a comparison to conventional digital acquisition systems.Ophthalmic surgery, lasers & imaging : the official journal of the International Society for Imaging in the Eye, 39 4
N. Bhagat, R. Grigorian, A. Tutela, M. Zarbin (2009)
Diabetic macular edema: pathogenesis and treatment.Survey of ophthalmology, 54 1
(1985)
Photocoagulation for diabetic macular edema : Early Treatment Diabetic Retinopathy Study Group report number 1
(2011)
panded 2 - year follow - up of ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema
D. Do, U. Schmidt-Erfurth, V. Gonzalez, C. Gordon, M. Tolentino, Alyson Berliner, R. Vitti, R. Rückert, R. Sandbrink, David Stein, Ke Yang, K. Beckmann, Jeffery Heier (2011)
The DA VINCI Study: phase 2 primary results of VEGF Trap-Eye in patients with diabetic macular edema.Ophthalmology, 118 9
K. Shimizu, K. Muraoka (1981)
Diabetic retinopathy. Is it a maculopathy? A super-wide fluorescein angiographic evaluation.Developments in ophthalmology, 2
David Brown, Q. Nguyen, D. Marcus, D. Boyer, Sunil Patel, L. Feiner, P. Schlottmann, A. Rundle, Jiameng Zhang, Roman Rubio, A. Adamis, J. Ehrlich, J. Hopkins (2013)
Long-term outcomes of ranibizumab therapy for diabetic macular edema: the 36-month results from two phase III trials: RISE and RIDE.Ophthalmology, 120 10
M. Sultan, Duo Zhou, J. Loftus, T. Dombi, K. Ice (2011)
A phase 2/3, multicenter, randomized, double-masked, 2-year trial of pegaptanib sodium for the treatment of diabetic macular edema.Ophthalmology, 118 6
E. Cunningham, A. Adamis, M. Altaweel, L. Aiello, N. Bressler, D. D’Amico, M. Goldbaum, D. Guyer, B. Katz, Manju Patel, S. Schwartz (2005)
A phase II randomized double-masked trial of pegaptanib, an anti-vascular endothelial growth factor aptamer, for diabetic macular edema.Ophthalmology, 112 10
A. Kaines, S. Oliver, S. Reddy, S. Schwartz (2009)
Ultrawide Angle Angiography for the Detection and Management of Diabetic RetinopathyInternational Ophthalmology Clinics, 49
Background and Objectives: To determine the efficacy, durability, and safety of a single treatment with intravitreal ranibizumab plus peripheral scatter laser (RaScaL) in patients with diabetic macular edema associated with peripheral retinal nonperfusion on ultrawide-field fluorescein angiography (UWFA). Study Design: A 6-month, randomized, controlled, prospective phase I/II study of 30 treatment-naïve eyes of 22 patients (8 bilateral patients) with visual impairment secondary to diabetic macular edema associated with peripheral nonperfusion on UWFA. Patients were randomized to receive ranibizumab plus UWFA-guided peripheral scatter laser (n = 15) or triamcinolone acetonide plus macular laser (n = 15). Results: At 6 months, the RaScaL group patients had fewer recurrences warranting retreatment (33% vs. 80%, p < 0.003). Mean change in final visual acuity and central foveal thickness were not statistically significant between groups. Conclusion: This pilot study suggests the efficacy, safety and durability of the RaScaL treatment regimen in patients with diabetic macular edema associated with peripheral nonperfusion on UWFA.
Ophthalmologica – Karger
Published: Jan 1, 2014
Keywords: Diabetic macular edema; Fluorescein angiography; Anti-VEGF; Ranibizumab; Laser photocoagulation; Combination therapy; Optical coherence tomography
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.